Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-10-16

FDA Approved: IXEMPRA — Original Application (R-Pharm US Operating, LLC)

View source ↗

Summary

FDA approved IXEMPRA (ixabepilone) through an original NDA for metastatic or locally advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ixempra (ixabepilone)

Snippet

ORIG AP for IXEMPRA (IXABEPILONE)